John Roback to Multiple Myeloma
This is a "connection" page, showing publications John Roback has written about Multiple Myeloma.
Connection Strength
0.084
-
Daratumumab (anti-CD38) induces loss of CD38 on red blood cells. Blood. 2017 06 01; 129(22):3033-3037.
Score: 0.084
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.